Global Biomarker Market in 2016 by Data Bridge Market Research


Posted October 1, 2018 by pankajukey1

Global Biomarker Market is expected to reach USD 85,927.95 million by 2024 from USD 28,091.78 million in 2016, at a CAGR of 15.1%.

 
Global Biomarker Market is expected to reach USD 85,927.95 million by 2024 from USD 28,091.78 million in 2016, at a CAGR of 15.1%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request For Sample- https://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market-3

The global biomarker market is highly concentrated to a few big players and rest to local players who cater to domestic markets only.
The global biomarker market is dominated by Bio-Rad Laboratories, Inc., followed by PerkinElmer, Inc. and Qiagen.
Other players in this market include
• Merck & Co., Inc.,
• EKF Diagnostics,
• Enzo biochem, Inc.,
• Meso Scale Diagnostics, LLC,
• Singulex, Inc.,
• Signosis, Inc.,
• and Cisbio Bioassays among others holds 32.0% of the global biomarker market in 2016.
BIO-RAD LABORATORIES INC.:
Founded in 1952 and headquartered in California, U.S. Bio-Rad laboratories, Inc. develops and commercializes the wide range of products and systems in the healthcare, life science research, analytical chemistry and few other areas, which is used for the separation of composite chemical and biological ingredients and for the analysis and purification of their components.
Bio-Rad operates its business in two industry segments named as life science and clinical diagnostics. Clinical Diagnostics segment manufactures, commercializes informatics systems, test systems, test kits and quality controls for the clinical laboratories.
Bio-rad has its presence across the globe in
United States, Australia, Greece, Portugal, Austria, Hong Kong, Russia, Belgium, France, Hungary, South Africa, Singapore, Brazil, India, Canada, Israel, South Korea, China, Italy, Spain, Czech Republic, Japan, Sweden, Denmark, Netherlands, Mexico, Switzerland, Egypt, Taiwan, Finland, New Zealand, Thailand, Norway, United Kingdom, Germany, and Poland.

Request For TOC- https://databridgemarketresearch.com/toc/?dbmr=global-biomarkers-market-3

PERKINELMER INC.:
Incorporated in 1947 and headquartered in Massachusetts, U.S. PerkinElmer, Inc. is a supplier and manufacturer of products, services and solutions for the food, diagnostics, industrial, environmental, life sciences research and laboratory services markets. The company operates its business through two business segments which includes discovery & analytical solutions and diagnostics. The diagnostics segment provides products and wide range of reagents, instruments, assay platforms, and software for hospitals, medical labs, clinicians, and medical research professionals. The segment focusses on the areas such as reproductive health, developing market diagnostics, and applied genomics.
PerkinElmer develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceutical products which are marketed directly or indirectly in U.S. and across the globe. The company commercializes products and services in over 150 countries.
QIAGEN:-
Founded in 1984 and headquartered at Hilden, Germany, Qiagen is engaged in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates through different business segments, namely Next-Gen Sequencing, Molecular Diagnostic, Life Sconce Research, Animal and Vet. Testing, Bioinformatics and others. The molecular diagnostic segment includes Oncology, Infectious Disease, Tuberculosis Management, Transplantation Testing and Women’s health. Next-Gen Sequencing covers GeneReader NGS System and QIAseq NGS Solutions.
Qiagen has its operations across the North America, Europe, Middle East and Africa, Asia-Pacific and rest of world. Some of its subsidiaries include
• Exiqon (Denmark),
• Cellestis (Australia),
• Tiangen Biotech Co. Ltd. (Beijing),
• Qiagen Ltd. (India),
• Ipsogen SA (France)
• and many more subsidiaries across the globe.

Inquiry Before Buying- https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market-3

About Us:
Data bridge Market Research is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our client’s needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few
Contact Us:
Data Bridge Market Research
Toll Free: +1-888-387-2818
Email - [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Databridge Market Research
Phone +1-888-387-2818
Business Address dharni
melghat
Country India
Categories Automotive , Biotech , Engineering
Tags global biomarkers research report , biomarkers market , biomarkers research report , global biomarkers industry analysis
Last Updated October 1, 2018